Startups
OncoLize develops injectable drug depots to treat rare and deadly tumour diseases. Using thin needles or catheters, we localize the small drug depot inside the solid tumour. While graudally eroding away, the depot slowly releases a range of well-known drugs inside the tumour. This is done at much higher concentrations than ever possible via oral medication or intravenous injections, yet the total load of the drug is limited to the volume of the tumour. The benefits are relevant: better treatment options for the patient and the doctor, with far less side-effects, and at much lower costs. We will start with GBM-tumours in the brain, and add pancreatric, prostate and urinary tract tumours to our portfolio as we develop a range of depots containing different Chemo-drugs. Our website will go live end of November.
Overview
Location
Netherlands, Limburg, Maastricht
Employees
1-10
Total raised
$1.7M
Founded date
2017
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| OncoLize | “OncoLize is preparing first human trials in pancreatic cancers and other aggressive tumor indications. We localize the delivery of well-proven drugs inside or next to the tumor. This will increase tumor eradication, reduce side-effects, an... |
Reviews 0
FAQ about OncoLize
When was OncoLize founded?
OncoLize was founded in 2017.
How much funding has OncoLize raised?
OncoLize has raised $1.7M in total across 1 funding round.
What has the press written about OncoLize?
Parsers VC has collected 2 articles mentioning OncoLize, among them “OncoLize”.
Is OncoLize still active?
Yes, OncoLize is active; its latest activity on Parsers VC dates from Apr 17, 2023.